Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
<p>Kaplan-Meier curves for Event-free Survival (EFS) in each dose group</p>
Uloženo v:
| Hlavní autor: | Yan Zhou (15053225) (author) |
|---|---|
| Další autoři: | Qingcheng Yang (15053228) (author), Yang Dong (15053231) (author), Tong Ji (15053234) (author), Bing Zhang (15053237) (author), Cheng Yang (15053240) (author), Shuier Zheng (15053243) (author), Lina Tang (15053246) (author), Chenliang Zhou (15053249) (author), Guowei Qian (15053252) (author), Yujing Huang (15053255) (author), Wenxi Yu (15053258) (author), Hongtao Li (15053261) (author), Yonggang Wang (15053264) (author), Aina He (15053267) (author), Zan Shen (15053270) (author), Qiyuan Bao (15053273) (author), Yingqi Hua (15053276) (author), Hongyu Bai (15053279) (author), Jiayi Zhao (15053282) (author), Xiaoyi Li (15053285) (author), Xiangrong Dai (15047025) (author), Jianjun Zhang (15053288) (author), Haiyan Hu (15053291) (author), Yang Yao (15053294) (author) |
| Vydáno: |
2025
|
| Témata: | |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Kaplan-Meier curves of (A) progression-free survival and (B) overall survival.
Autor: Lu Xie (20428615)
Vydáno: (2025) -
Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
Autor: William Kelly (15439117)
Vydáno: (2025) -
Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
Autor: William Kelly (15439117)
Vydáno: (2025) -
Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
Autor: Amir T. Fathi (15313195)
Vydáno: (2025) -
Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
Autor: Amir T. Fathi (15313195)
Vydáno: (2025)